Literature DB >> 18645491

Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients.

Mahmoud Sadeghi1, Volker Daniel, Cord Naujokat, Paul Schnitzler, Jan Schmidt, Arianeb Mehrabi, Martin Zeier, Gerhard Opelz.   

Abstract

OBJECTIVE: Pre- and posttransplant predisposing factors for cytomegalovirus (CMV) activation and disease are not well defined. The aim of this study was to examine whether there are differences in plasma cytokine levels pretransplant, before and during CMV replication in renal transplant recipients.
MATERIAL AND METHODS: We studied 76 renal transplant recipients in whom CMV-DNA was studied at regular intervals posttransplant. Thirty-eight patients developed CMV viremia posttransplant (CMV-DNA-positive). Thirty-eight patients had no detectable CMV-DNA posttransplant (CMV-DNA-negative). Cytokine and cytokine receptors/antagonists plasma levels were measured pretransplant, and pre-, during, and after CMV-viremia in CMV-DNA-positive patients and at similar time points in CMV-DNA-negative transplant recipients.
RESULTS: Compared with pretransplant, after transplantation soluble (s) plasma interleukin (IL)-2 receptor (R), IL-6, and interferon-gamma (IFN-gamma) decreased in both groups (CMV-DNA-positive: P=0.002; P=0.028; P=0.032; CMV-DNA-negative: P=0.001; P=0.040; P=0.030) whereas IL-10 remained constant in both groups (P=n.s.). During CMV viremia, sIL-2R (P=0.015) and IL-6 (P=0.006) increased compared with previremia but remained constant in CMV-DNA-negative patients matched for the day of investigation (P=n.s.). Simultaneously, IFN-gamma increased in CMV-DNA-negative patients (P=0.008) and remained constant in CMV-DNA-positive patients (P=n.s.). During CMV viremia, IL-10 (P=0.002) and sIL-2R (P=0.007) were significantly higher in CMV-DNA-positive than CMV-DNA-negative patients investigated at similar time points.
CONCLUSION: Our results indicate that CMV replication in renal transplant recipients is associated with increased sIL-2R, IL-6, and IL-10 and decreased IFN-gamma plasma levels, pointing to a monocyte/Th2 activation and a Th1 blockade. The high IL-10 might decrease the IFN-gamma plasma levels in CMV-DNA-positive patients. Th1 deficiency in CMV-DNA-positive patients might promote development of CMV disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18645491     DOI: 10.1097/TP.0b013e31817b063d

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

Authors:  Corinna La Rosa; Ajit P Limaye; Aparna Krishnan; Gideon Blumstein; Jeff Longmate; Don J Diamond
Journal:  Transpl Int       Date:  2011-06-14       Impact factor: 3.782

2.  Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.

Authors:  Ajit P Limaye; Corinna La Rosa; Jeff Longmate; Don J Diamond
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

3.  Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease.

Authors:  A Krishnan; W Zhou; S F Lacey; A P Limaye; D J Diamond; C La Rosa
Journal:  Transpl Infect Dis       Date:  2010-01-11       Impact factor: 2.228

4.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

5.  Association between Interleukin-21, 23 and 27 Expression and Protein Level with Cytomegalovirus Infection in Liver Transplant Recipients.

Authors:  A Afshari; R Yaghobi; M H Karimi; N Azarpira; B Geramizadeh; M Darbouy; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2020

6.  Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice.

Authors:  Yajarayma J Tang-Feldman; G Raymond Lochhead; Stephanie R Lochhead; Cindy Yu; Claire Pomeroy
Journal:  Inflamm Res       Date:  2010-10-05       Impact factor: 4.575

7.  Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.

Authors:  Michaela Döring; Karin Melanie Cabanillas Stanchi; Markus Mezger; Annika Erbacher; Judith Feucht; Matthias Pfeiffer; Peter Lang; Rupert Handgretinger; Ingo Müller
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

8.  IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.

Authors:  Mahmoud Sadeghi; Imad Lahdou; Gerhard Opelz; Arianeb Mehrabi; Martin Zeier; Paul Schnitzler; Volker Daniel
Journal:  BMC Immunol       Date:  2016-10-03       Impact factor: 3.615

9.  The human cytomegalovirus glycoprotein pUL11 acts via CD45 to induce T cell IL-10 secretion.

Authors:  Jasmin Zischke; Panagiota Mamareli; Claudia Pokoyski; Ildar Gabaev; Sabine Buyny; Roland Jacobs; Christine S Falk; Matthias Lochner; Tim Sparwasser; Thomas F Schulz; Penelope C Kay-Fedorov
Journal:  PLoS Pathog       Date:  2017-06-19       Impact factor: 6.823

Review 10.  Cytokine-Mediated Induction and Regulation of Tissue Damage During Cytomegalovirus Infection.

Authors:  Mathew Clement; Ian R Humphreys
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.